Although the edible alga Petalonia binghamiae is extensively consumed as a health-promoting food by Northeast Asians, little is known about the biomedical efficacies of P. binghamiae. In this report, we investigated the novel efficacy of P. binghamiae extract (Pb-E01) using LX-2 and HepG2 cells. Pb-E01 inhibited TGF-β1-induced cell proliferation and gene expression in LX-2 cells. In addition, Pb-E01 reduced H 2 O 2 -induced reactive oxygen species (ROS) and alanine aminotransferase (ALT) activity in HepG2 cells. According to these results, we suggest that Pb-E01 plays a functional role in suppressing liver fibrogenesis.
A variety of marine-derived compounds have been isolated and identified, and their therapeutic effects and pharmacological properties have been characterized [1] . The extracts of brown alga (Padina boergesenii), carotenoids, have been proposed to have a hepatoprotective role in carbon tetrachloride (CCl4)-induced oxidative damage and liver fibrosis [2] . In addition, bioactive phenolic compounds (chlorogenic acid, pyrogallol, rutin and coumaric acid) from the sea cucumber are known to have a hepatoprotective effect in thioacetamide (TAA)-induced liver fibrosis in rats [3] . β-Chitosan from the squid Sepioteuthis lessoniana also showed hepatoprotective activity against CCl4-induced oxidative stress in Wistar rats [4] . Therefore, these marinederived bioactive compounds might support the development of new drugs/means for the treatment of liver disease.
Marine algae are rich in minerals, vitamins and dietary fibers. The edible brown alga, Petalonia binghamiae, is recognized and consumed by Northeast Asian people as a healthy food. P. binghamiae belongs to the Scytosiphonaceae family and is distributed in the middle Pacific coast. Some compounds from P. binghamiae were shown to inhibit DNA polymerase α and have negative effects on adipocyte differentiation in 3T3-L1 cells [5, 6] . In addition, the extracts of P. binghamiae were proposed to have anti-oxidant properties [7] . In this study, we report the novel efficacy of P. binghamiae extract (Pb-E01) inhibiting TGF-β1 or H 2 O 2 -induced liver fibrosis in LX-2 and HepG2 cells.
Liver fibrosis is the result of various types of chronic liver damage, including virus infection, autoimmune liver diseases and sustained alcohol abuse [8] . Activation of hepatic stellate cells (HSC) is recognized as a major source of the matrix proteins and plays an important role in the development and maintenance of hepatic fibrosis [9, 10] . The LX-2 human cell lines have been widely used for fibrosis studies, because they maintain the characteristics of activated stellate cells [11] . Here, we used LX-2 cells to examine the cellular effects of Pb-E01 in liver fibrosis. The effect of Pb-E01 on TGF-β1-induced cell proliferation was investigated using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay in LX-2 cells. Transforming growth factor (TGF-β1) is the most powerful pro-fibrogenic cytokine [12] . TGF-β1 secreted by activated Kupffer cells and sinusoidal endothelial cells, induces apoptosis of hepatocytes and elicits the activation and recruitment of inflammatory cells into damaged liver [12] . As shown in Figure  1A , treatment of TGF-β1 to LX-2 cells stimulated the growth of HSC compared to control. However, Pb-E01 treatment was able to
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inhibit TGF-β1-induced HSC growth ( Figure 1A) . Similar results were also observed in diphenyleneiodonium (DPI) [13] -treated cells ( Figure 1A) . Therefore, our results suggest that Pb-E01 suppresses the proliferation of activated HSC and may prevent liver fibrosis. On the other hand, cytotoxic effect by Pb-E01 on human kidney epithelial cells (HEK-239) was not observed, suggesting that Pb-E01 does not exhibit a negative effect on human normal cells ( Figure 1B ). Once HSCs are activated, production of matrix proteins and HSC proliferation are enhanced and increased expression of collagen type I alpha 1 chain (COLIA1) is observed, and these, indeed, elicit liver cirrhosis [14] . As shown in Figure 1C , treatment of Pb-E01 to LX-2 cells significantly reduced TGF-β1-induced COLIA1 expression in a dose-dependent manner. Therefore, our results suggest that Pb-E01 plays a negative role in the proliferation of activated HSCs by suppressing TGF-β1-induced gene expression in LX-2 cells.
Oxidative stress plays a critical role in liver fibrogenesis [15] . Damaged hepatocytes play a major role in the production of reactive oxygen species (ROS) during the early stages of liver fibrosis [12] . Activated HSCs can also produce ROS [15] . In this study, we also used HepG2 cells, human liver cancer cells, to examine the cellular effects of Pb-E01 in liver fibrogenesis. As shown in Figure 2A , Pb-E01 largely reduced H 2 O 2 -induced ROS in HepG2 cells. Therefore, these results suggest that Pb-E01 has a negative effect on H 2 O 2-induced liver fibrogenesis by reducing ROS in HepG2 cells.
Biochemical analysis of serum enzyme, such as alanine aminotransferase (ALT), was performed to estimate the extent of liver injury. ALT is found in serum and various bodily tissues, but is usually associated with liver. It is commonly measured as a part of a diagnostic liver test to determine liver health [16] . As shown in Figure 2B , Pb-E01 reduced H 2 O 2 -induced ALT activity in HepG2 cells. Therefore, Pb-E01 appears to inhibit ALT activity by attenuating H 2 O 2 -induced liver damage in HepG2 cells.
In conclusion, here we propose that Pb-E01 can suppress TGF-β1-or H 2 O 2 -induced liver fibrosis in LX-2 and HepG2 cells. Pb-E01 has a functional role in protecting hepatocytes and may be effective in minimizing liver fibrosis.
Experimental
Extraction of Pb-01: The air-dried material (15 g) of P. binghamiae was chopped into small pieces and extracted using EtOH (95 %) for 24 hours in a heating mantle (MS-E103, Misung Scientific). After the EtOH extraction, Pb-01 was filtered using a 110 nm filter paper (No. 2, Advantec, Toyo) and Pb-01 was concentrated using a rotary vacuum evaporator (N-1000, EYELA). The concentrated Pb-01 was dried using a vacuum freeze dryer (FDU-8606, Operon) and the yield of the dried Pb-01 was measured. The dried Pb-01 was finally dissolved in DMSO.
MTS assay:
The cells were seeded in a 96-well (4 × 10 3 cells/well) and treated with TGF-β1 (10 ng/mL) alone or in combination with different doses of Pb-E01 for 48 h. After incubation, 20 μL of the MTS working solution (2 mg/mL in phosphate buffered saline (PBS)) was added to each well and incubated at 37 °C for 4 h. Absorbance at 490 nm was measured using a microplate reader (Victor 2 1420 Multilabel counter, PerkinElmer) and cell viability was determined as the percentage of MTS reduction, assuming the absorbance of control cells as 100%.
